S1P<sub>3</sub> Receptor Mediates the Proinflammatory Effect of the Endocannabinoid 2-Arachidonoylglycerol in Endometriotic Epithelial Cells. [PDF]
Raeispour M +9 more
europepmc +1 more source
Recent Advances in Interventions Targeting Remyelination and a Systematic Review of Remyelinating Effects of Approved Disease-Modifying Treatments for Multiple Sclerosis. [PDF]
De Keersmaecker AV +11 more
europepmc +1 more source
Transcriptional signature of rapidly responding NK cells reveals S1P5 and CXCR4 as anti-tumor response disruptors. [PDF]
Puig-Gámez M +4 more
europepmc +1 more source
Post-resection delivery of a TLR7/8 agonist from a biodegradable scaffold achieves immune-mediated glioblastoma clearance and protection against tumor challenge in mice. [PDF]
Graham-Gurysh EG +19 more
europepmc +1 more source
Potential new targets for rheumatic diseases. [PDF]
Braun J, Hiepe F.
europepmc +1 more source
Deletion of sphingosine 1-phosphate receptor 1 in myeloid cells reduces hepatic inflammatory macrophages and attenuates MASH. [PDF]
Parthasarathy G +14 more
europepmc +1 more source
Inhibition of Sphingosine-1-Phosphate Receptor 2 (S1P<sub>2</sub>) Attenuates Imiquimod-Induced Psoriasis-Like Skin Inflammation in BALB/c Mice. [PDF]
Lee JH, Im DS.
europepmc +1 more source
Gaps in PLTP mechanism research in sepsis-associated acute kidney injury and improvement strategies based on new evidence. [PDF]
Liang D, Li X.
europepmc +1 more source
Peroxiredoxin 6 Alone or in Combination with Fingolimod Ameliorates EAE. [PDF]
Lunin SM +9 more
europepmc +1 more source

